NSAIDs won’t protect ultra-marathoners’ muscles
Taking non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen during endurance events does not help prevent muscle damage or next-day muscle soreness, a study in ultra-marathoners indicates.
In fact, using NSAIDs during competition could actually be bad for muscles, Dr. Steven McAnulty of Appalachian State University in Boone, North Carolina and colleagues found.
Breast cancer gene mutation more common in Hispanic, young black women, Stanford/NCCC study finds
A genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.
Researchers at the Stanford University School of Medicine and the Northern California Cancer Center reported the finding from a study of 3,181 breast cancer patients in Northern California. It revealed that although Ashkenazi Jewish women with breast cancer had the highest rate of the BRCA1 mutation at 8.3 percent, Hispanic women with breast cancer were next most likely, with a rate of 3.5 percent. Non-Hispanic whites with breast cancer showed a 2.2 percent rate, followed by 1.3 percent of African-American women of all ages and 0.5 percent in Asian-American women. Of the African-American breast cancer patients under age 35, 16.7 percent had the mutation.
